CN115350133A - Preparation and application of skin-whitening and soothing nano-structure lipid carrier - Google Patents

Preparation and application of skin-whitening and soothing nano-structure lipid carrier Download PDF

Info

Publication number
CN115350133A
CN115350133A CN202211056118.7A CN202211056118A CN115350133A CN 115350133 A CN115350133 A CN 115350133A CN 202211056118 A CN202211056118 A CN 202211056118A CN 115350133 A CN115350133 A CN 115350133A
Authority
CN
China
Prior art keywords
whitening
phase
parts
soothing
lipid carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211056118.7A
Other languages
Chinese (zh)
Inventor
郑丹阳
朱永闯
胡翠萍
詹朝阳
龚盛昭
黄金辉
梁世劲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Industry Technical College
Original Assignee
Guangdong Industry Technical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Industry Technical College filed Critical Guangdong Industry Technical College
Priority to CN202211056118.7A priority Critical patent/CN115350133A/en
Publication of CN115350133A publication Critical patent/CN115350133A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82Preparation or application process involves sonication or ultrasonication

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses preparation and application of a nano-structure lipid carrier for whitening and relieving skin. The nano-structured lipid carrier comprises the following components in parts by weight: 10 to 30 parts of whitening active matter, 10 to 20 parts of soothing active matter, 25 to 36 parts of grease, 1 to 4 parts of emulsifier and the balance of deionized water. According to the invention, through optimizing a preparation formula and a process, whitening agents with different mechanisms are stably wrapped in the nano-structure lipid carrier, so that the whitening and relieving nano-structure lipid carrier with strong efficacy, high stability and high safety is obtained. The active matter with the whitening and relieving effects is wrapped in the nano-structure lipid carrier, and can be further applied to various skin care cosmetics to realize the effects of fading color spots and whitening. Meanwhile, the skin can be relieved, and the irritation can be reduced. The skin whitening agent enables consumers to whiten skin, reduces irritation to the skin and enhances the penetration of active substances.

Description

一种美白舒缓的纳米结构脂质载体的制备及应用Preparation and application of a whitening and soothing nanostructured lipid carrier

技术领域technical field

本发明涉及一种美白舒缓的纳米结构脂质载体的制备方法,同时也涉及该美白舒缓的纳米结构脂质载体作为化妆品主要有效成分的应用,属于日用护肤品技术领域。The invention relates to a preparation method of a whitening and soothing nanostructured lipid carrier, and also relates to the application of the whitening and soothing nanostructured lipid carrier as a main active ingredient of cosmetics, belonging to the technical field of daily skin care products.

背景技术Background technique

爱美之心人皆有之,皮肤白皙是东方女性的普遍诉求之一。追求“美白”,主要是从四个方面抑制黑色素:一是阻碍黑色素生成。黑色素是由黑色素细胞分泌的生物色素,它是由酪氨酸经过酪氨酸酶作用,氧化生成多巴,多巴经氧化、脱羧等反应转变成吲哚醌,最后吲哚醌聚合为黑色素。通过使用美白功效成分化妆品,可以从源头减缓黑色素生成,如熊果苷等;二是抑制酪氨酸酶活性,调节黑色素形成的信号通路与微噬菌体相关转录因子(MITF)有关,下调MITF活性可以降低相关酶的表达,从而抑制黑色素的形成,如白藜芦醇、水仙鳞茎醇提取物等;三是抑制黑色素的转移,阻止黑色素向上层角质形成细胞的转移,如烟酰胺等;四是促进新陈代谢,去除黑色素角质细胞,使皮肤恢复白皙,如各种酸类等。Everyone has a desire for beauty, and fair skin is one of the common demands of oriental women. The pursuit of "whitening" mainly inhibits melanin from four aspects: one is to hinder the production of melanin. Melanin is a biological pigment secreted by melanocytes. It is oxidized to dopa by tyrosine through the action of tyrosinase. Dopa is converted into indole quinone through oxidation, decarboxylation and other reactions, and finally indole quinone is polymerized into melanin. By using cosmetics with whitening functional ingredients, melanin production can be slowed down from the source, such as arbutin, etc.; the second is to inhibit tyrosinase activity, the signaling pathway that regulates melanin formation is related to microphage-related transcription factor (MITF), and down-regulating MITF activity can Reduce the expression of related enzymes, thereby inhibiting the formation of melanin, such as resveratrol, narcissus bulb alcohol extract, etc.; the third is to inhibit the transfer of melanin, preventing the transfer of melanin to the upper keratinocytes, such as nicotinamide, etc.; the fourth is to promote Metabolize, remove melanin keratinocytes, restore fair skin, such as various acids, etc.

发明内容Contents of the invention

本发明所要解决的技术问题在于提供一种美白舒缓的纳米结构脂质载体的制备方法,其步骤至少包括:The technical problem to be solved by the present invention is to provide a method for preparing a whitening and soothing nanostructured lipid carrier, the steps of which at least include:

步骤1:紫玉兰叶提取物的制备Step 1: Preparation of Purple Magnolia Leaf Extract

将新鲜的紫玉兰叶进行清洗干净后,沥水烘干;干燥至表面无水分,低于原始重量的70%之后,用研磨机将其研磨成紫玉兰叶粉末;After cleaning the fresh purple magnolia leaves, drain and dry them; dry them until the surface is free of moisture, which is less than 70% of the original weight, and then use a grinder to grind them into purple magnolia leaf powder;

将干燥的紫玉兰叶粉末用无水乙醇超声破碎提取3次,合并提取液,减压蒸馏去除有机溶剂后得到紫玉兰叶提取物;The dried magnolia leaf powder was ultrasonically crushed and extracted with absolute ethanol for 3 times, the extracts were combined, and the organic solvent was distilled off under reduced pressure to obtain the magnolia leaf extract;

步骤2:库拉索芦荟提取物的制备Step 2: Preparation of Aloe Vera Extract

将库拉索芦荟反复冲洗干净,表面擦干后剔除其边刺,将表皮从透明的凝胶表面剥离,用清水洗去凝胶表面的黄色汁液;Rinse the aloe vera repeatedly, dry the surface and remove its side thorns, peel off the epidermis from the transparent gel surface, and wash off the yellow juice on the gel surface with water;

将库拉索芦荟切成小块,用组织搅拌机搅成匀浆,匀浆液离心12000r/min,15min后除去沉淀,得到库拉索芦荟凝胶汁;Cut the aloe vera into small pieces, stir it into a homogenate with a tissue mixer, centrifuge the homogenate at 12000r/min, remove the precipitate after 15min, and obtain the aloe vera gel juice;

将库拉索芦荟凝胶汁在旋转蒸发仪中,在60℃的条件下真空浓缩到原体积的35%后,再加入10倍体积的95%乙醇,降温至4℃下醇沉24h;Concentrate the aloe vera gel juice in a rotary evaporator to 35% of the original volume in vacuum at 60°C, then add 10 times the volume of 95% ethanol, and cool down to 4°C for alcohol precipitation for 24 hours;

将得到的库拉索芦荟混合沉淀物按5000r/min转速离心15min,收集沉淀物,冷冻干燥即得库拉索芦荟粗提取物;The obtained Aloe Vera mixed sediment was centrifuged at a speed of 5000r/min for 15min, the precipitate was collected, and freeze-dried to obtain the Aloe Vera crude extract;

将10g库拉索芦荟粗提取物溶解于1000mL去离子水中制备1.0%的水溶液;10g of Aloe vera crude extract was dissolved in 1000mL of deionized water to prepare a 1.0% aqueous solution;

在室温中向上述溶液中缓慢加入硫酸铵溶液并快速搅拌至库拉索芦荟粗提取物溶液中硫酸铵的质量分数达到40%,将混合产物置于4℃环境中放置24h;Slowly add ammonium sulfate solution to the above solution at room temperature and stir rapidly until the mass fraction of ammonium sulfate in the Aloe vera crude extract solution reaches 40%, and place the mixed product at 4°C for 24 hours;

然后将上述产物在5000r/min转速下离心15min,将离心产生的沉淀复溶于水并透析至无硫酸铵残留,经过冷冻干燥后得到库拉索芦荟提取物;Then the above product was centrifuged at 5000r/min for 15min, the precipitate produced by centrifugation was redissolved in water and dialyzed until there was no ammonium sulfate residue, and the Aloe vera extract was obtained after freeze-drying;

步骤3:物料准备Step 3: Material Preparation

按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:

10~30份美白活性成分、10~20份舒缓活性成分、25~36份油相的组分、1~4份乳化剂为,余量为去离子水;10-30 parts of whitening active ingredients, 10-20 parts of soothing active ingredients, 25-36 parts of oil phase components, 1-4 parts of emulsifier, and the balance is deionized water;

其中舒缓活性成分步骤1和2的方法所制备的紫玉兰叶提取物和库拉索芦荟提取物;Wherein the purple magnolia leaf extract and the aloe vera extract prepared by the method of steps 1 and 2 of the soothing active ingredient;

步骤4:制备油相Step 4: Prepare the Oil Phase

将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温60~80℃,得到油相;The whitening active ingredient, the soothing active ingredient and the components of the oil phase in step 3 are heated and stirred to dissolve, and kept at 60-80°C to obtain the oil phase;

步骤5:制备水相Step 5: Prepare the Water Phase

将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温60~80℃,得到水相;The emulsifier and deionized water in step 3 are heated and stirred to dissolve, and kept at 60-80°C to obtain the water phase;

步骤6:制备初乳Step 6: Prepare Colostrum

将由步骤5得到的水相在剪切力为10000~16000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质2~10min,得到初乳;Slowly add the water phase obtained in step 5 into the oil phase obtained in step 4 under the action of a shear force of 10,000-16,000 r/min, and then homogenize for 2-10 minutes to obtain colostrum;

步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers

将步骤6得到的初乳,通过高压均质机在压力为500~800bar作用下均质2~5次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 2 to 5 times by a high-pressure homogenizer under the action of a pressure of 500-800 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.

具体的,所述美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。Specifically, the particle size of the whitening and soothing nanostructured lipid carrier is between 200nm and 600nm.

具体的,所述美白活性成分为5~15份α-熊果苷和5~15份白藜芦醇。Specifically, the whitening active ingredient is 5-15 parts of α-arbutin and 5-15 parts of resveratrol.

具体的,所述油相的组分为10~16份乳木果油、5~11份单甘脂、10~15份月桂醇、1~6份辛酸癸酸甘油三酯、2~8份棕榈酸异辛酯。Specifically, the components of the oil phase are 10-16 parts of shea butter, 5-11 parts of monoglyceride, 10-15 parts of lauryl alcohol, 1-6 parts of caprylic and capric triglycerides, 2-8 parts of Isooctyl Palmitate.

具体的,所述乳化剂为:1~4份司盘83和2~3份吐温80。Specifically, the emulsifier is: 1-4 parts of Span 83 and 2-3 parts of Tween 80.

利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白乳液,该美白乳液按质量百分比计包括以下组分:A whitening emulsion prepared by using the whitening and soothing nano-structured lipid carrier, the whitening emulsion includes the following components by mass percentage:

Figure BDA0003821579500000031
Figure BDA0003821579500000031

利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白乳液,其制备方法包括如下步骤:A kind of whitening emulsion that utilizes the described whitening and soothing nanostructure lipid carrier to participate in the preparation, and its preparation method comprises the following steps:

将A相、B相、C相的各个组分分别搅拌混合后备用;首先将A和B两相分别加热至80℃,溶解混合均匀,将A相加入到B相中,并均质5min,在转速为8000rpm/min搅拌,随后冷却至50℃时,加入C相并均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B, and Phase C separately and set aside; first, heat Phase A and Phase B to 80°C, dissolve and mix evenly, add Phase A to Phase B, and homogenize for 5 minutes. Stir at a rotation speed of 8000rpm/min, then cool to 50°C, add phase C and homogenize for 2min, age for 24h and pack.

利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白面膜液,按质量百分比计包括以下组分:A kind of whitening facial mask liquid prepared by utilizing the nano-structured lipid carrier for whitening and soothing, comprising the following components by mass percentage:

Figure BDA0003821579500000041
Figure BDA0003821579500000041

利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白面膜液,其制备方法包括如下步骤:A kind of whitening facial mask liquid that utilizes the nanostructure lipid carrier of described whitening and soothing to participate in the preparation, and its preparation method comprises the following steps:

将A相、B相、C相的各个组分分别搅拌混合后备用;依次将A、B两相称好,将A和B相加热至80℃,溶解到无颗粒,转速为1000rpm/min搅拌均匀,将B相加入到A相中,均质5min,搅拌降温至50℃,加入C相,转速为800rpm/min低速均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B and Phase C separately and set aside; weigh Phases A and B in sequence, heat Phases A and B to 80°C, dissolve until there are no particles, and stir evenly at a speed of 1000rpm/min , add phase B to phase A, homogenize for 5 minutes, stir and cool down to 50°C, add phase C, homogenize at a low speed of 800rpm/min for 2min, age for 24h and pack.

与现有技术相比较,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

本发明利用消费者对美白功效化妆品的需求,结合肌肤的敏感性,制备了一种兼具美白和舒缓功效的纳米结构脂质载体,让消费者在爱美的同时,降低因敏感肌带来的困扰。本发明所制备的产品,将活性物包裹在纳米结构脂质载体中兼具有美白和舒缓功效,使载体具有美白功效的同时,也能起到舒缓功效作用,降低皮肤刺激。The present invention utilizes consumers' needs for whitening cosmetics and combines skin sensitivity to prepare a nanostructured lipid carrier with both whitening and soothing effects, allowing consumers to reduce the troubles caused by sensitive skin while loving beauty . The product prepared by the invention has both whitening and soothing effects by encapsulating the active substance in the nanostructured lipid carrier, so that the carrier can not only have the whitening effect, but also play a soothing effect and reduce skin irritation.

附图说明Description of drawings

图1为对应浓度下美白舒缓的纳米结构脂质载体(样品1)、未包覆活性物纳米结构脂质载体的原料溶液(样品2)对斑马鱼胚胎安全性的影响示意图(P<0.01**;P<0.001***);Figure 1 is a schematic diagram of the effect of the whitening and soothing nanostructured lipid carrier (sample 1) and the raw material solution (sample 2) of the nanostructured lipid carrier not coated with active substances on the safety of zebrafish embryos at corresponding concentrations (P<0.01* *; P<0.001***);

图2为对应浓度下美白舒缓的纳米结构脂质载体对斑马鱼胚胎美白效果的影响示意图(P<0.01**;P<0.001***;P<0.0001****);Figure 2 is a schematic diagram of the effect of whitening and soothing nanostructured lipid carriers on the whitening effect of zebrafish embryos at corresponding concentrations (P<0.01**; P<0.001***; P<0.0001****);

图3为不同浓度下美白舒缓的纳米结构脂质载体对斑马鱼胚胎舒缓功效的影响示意图(P<0.0001****)。Figure 3 is a schematic diagram of the effect of different concentrations of whitening and soothing nanostructured lipid carriers on the soothing effect of zebrafish embryos (P<0.0001****).

具体实施方式Detailed ways

下面将结合附图对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明的一部分实施例,而不是全部的实施例。基于本发明提供的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions of the present invention will be clearly and completely described below in conjunction with the accompanying drawings. Apparently, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments provided by the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts fall within the protection scope of the present invention.

在本发明的描述中,需要说明的是,术语“中心”、“上”、“下”、“左”、“右”、“竖直”、“水平”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”、“第三”仅用于描述目的,而不能理解为指示或暗示相对重要性。In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer" etc. The indicated orientation or positional relationship is based on the orientation or positional relationship shown in the drawings, and is only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the referred device or element must have a specific orientation, or in a specific orientation. construction and operation, therefore, should not be construed as limiting the invention. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and should not be construed as indicating or implying relative importance.

在本发明的描述中,需要说明的是,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。In the description of the present invention, it should be noted that unless otherwise specified and limited, the terms "installation", "connection" and "connection" should be understood in a broad sense, for example, it can be a fixed connection or a detachable connection. Connected, or integrally connected; it can be mechanically connected or electrically connected; it can be directly connected or indirectly connected through an intermediary, and it can be the internal communication of two components. Those of ordinary skill in the art can understand the specific meanings of the above terms in the present invention in specific situations.

实施例:紫玉兰叶提取物的制备Embodiment: the preparation of purple magnolia leaf extract

步骤1:处理紫玉兰叶Step 1: Processing the Purple Magnolia Leaves

将新鲜的紫玉兰叶进行清洗干净后,沥水烘干。干燥至表面无水分,低于原始重量的70%之后,用研磨机将其研磨成紫玉兰叶粉末。After washing the fresh purple magnolia leaves, drain and dry them. After drying until the surface is free of moisture and less than 70% of the original weight, it is ground into purple magnolia leaf powder with a grinder.

步骤2:紫玉兰叶的提取Step 2: Extraction of Purple Magnolia Leaves

将干燥的紫玉兰叶粉末用无水乙醇超声破碎提取3次,合并提取液,减压蒸馏去除有机溶剂后得到紫玉兰叶提取物。The dried magnolia leaf powder was ultrasonically crushed and extracted three times with absolute ethanol, the extracts were combined, and the organic solvent was distilled off under reduced pressure to obtain the magnolia leaf extract.

实施例:库拉索芦荟提取物的制备Example: Preparation of Aloe Vera Extract

步骤1:处理库拉索芦荟Step 1: Processing Aloe Vera

将库拉索芦荟反复冲洗干净,表面擦干后剔除其边刺,将表皮从透明的凝胶表面剥离,用清水洗去凝胶表面的黄色汁液。Rinse the aloe vera repeatedly, dry the surface and remove its side thorns, peel off the epidermis from the transparent gel surface, and wash off the yellow juice on the gel surface with water.

步骤2:库拉索芦荟的提取Step 2: Extraction of Aloe Vera

将库拉索芦荟切成小块,用组织搅拌机搅成匀浆,匀浆液离心12000r/min,15min后除去沉淀,得到库拉索芦荟凝胶汁。Cut the aloe vera into small pieces, stir it into a homogenate with a tissue mixer, centrifuge the homogenate at 12000r/min, remove the precipitate after 15min, and obtain the aloe vera gel juice.

将库拉索芦荟凝胶汁在旋转蒸发仪中,在60℃的条件下真空浓缩到原体积的35%后,再加入10倍体积的95%乙醇,降温至4℃下醇沉24h。The aloe vera gel juice was vacuum-concentrated to 35% of the original volume at 60°C in a rotary evaporator, then 10 times the volume of 95% ethanol was added, and the temperature was lowered to 4°C for alcohol precipitation for 24 hours.

将得到的库拉索芦荟混合沉淀物按5000r/min转速离心15min,收集沉淀物,冷冻干燥即得库拉索芦荟粗提取物。The obtained Aloe vera mixed sediment was centrifuged at a speed of 5000r/min for 15min, the precipitate was collected, and freeze-dried to obtain a crude Aloe vera extract.

步骤3:库拉索芦荟提取物的分离纯化Step 3: Separation and Purification of Aloe Vera Extract

将10g库拉索芦荟粗提取物溶解于1000mL去离子水中制备1.0%的水溶液。A 1.0% aqueous solution was prepared by dissolving 10 g of Aloe vera crude extract in 1000 mL of deionized water.

在室温中向上述溶液中缓慢加入硫酸铵溶液并快速搅拌硫酸铵溶液并快速搅拌至库拉索芦荟粗提取物溶液中硫酸铵的质量分数达到40%后,将混合产物置于4℃环境中放置24h。Slowly add ammonium sulfate solution to the above solution at room temperature and stir the ammonium sulfate solution rapidly until the mass fraction of ammonium sulfate in the Aloe vera crude extract solution reaches 40%, then place the mixed product in a 4°C environment Leave it for 24h.

然后将上述产物在5000r/min转速下离心15min,将离心产生的沉淀复溶于水并透析至无硫酸铵残留,经过冷冻干燥后得到库拉索芦荟提取物。Then the above product was centrifuged at 5000r/min for 15min, the centrifuged precipitate was redissolved in water and dialyzed until no ammonium sulfate remained, and the Aloe vera extract was obtained after freeze-drying.

以下实施例中均采用上述方法制备的紫玉兰叶提取物和库拉索芦荟提取物。The magnolia leaf extract and Aloe vera extract prepared by the above method were used in the following examples.

实施例1Example 1

制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.

步骤3:物料准备Step 3: Material Preparation

按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:

美白活性成分包括:8份α-熊果苷、6份白藜芦醇。Whitening active ingredients include: 8 parts of α-arbutin, 6 parts of resveratrol.

舒缓活性成分包括:6份紫玉兰叶提取物、8份库拉索芦荟提取物。Soothing active ingredients include: 6 parts Magnolia Leaf Extract, 8 parts Aloe Vera Extract.

油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.

固体油脂包括:11份乳木果油、7份单甘脂、10份月桂醇。Solid fats include: 11 parts of shea butter, 7 parts of monoglyceride, and 10 parts of lauryl alcohol.

液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.

乳化剂为:2份的司盘83、1份的吐温80,The emulsifier is: 2 parts of Span 83, 1 part of Tween 80,

再加入35份去离子水补足重量份数。Then add 35 parts of deionized water to make up the parts by weight.

步骤4:制备油相Step 4: Prepare the Oil Phase

将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温60℃,得到油相;The whitening active ingredient, the soothing active ingredient and the oil phase components in step 3 are heated and stirred to dissolve, and kept at 60°C to obtain the oil phase;

步骤5:制备水相Step 5: Prepare the Water Phase

将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温60℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, and keep warm at 60°C to obtain the water phase;

步骤6:制备初乳Step 6: Prepare Colostrum

将由步骤5得到的水相在剪切力为12000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质4min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 12000r/min, and then homogenize for 4 minutes to obtain colostrum;

步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers

将步骤6得到的初乳,通过高压均质机在压力为500bar作用下均质4次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 4 times by a high-pressure homogenizer under a pressure of 500 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.

检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.

实施例2Example 2

制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.

步骤3:物料准备Step 3: Material Preparation

按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:

美白活性成分包括:8份α-熊果苷、6份白藜芦醇。Whitening active ingredients include: 8 parts of α-arbutin, 6 parts of resveratrol.

舒缓活性成分包括:7份紫玉兰叶提取物、8份库拉索芦荟提取物。Soothing active ingredients include: 7 parts Magnolia Leaf Extract, 8 parts Aloe Vera Extract.

油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.

固体油脂包括:11份乳木果油、7份单甘脂、10份月桂醇。Solid fats include: 11 parts of shea butter, 7 parts of monoglyceride, and 10 parts of lauryl alcohol.

液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.

乳化剂为:1份的司盘83、2份的吐温80,The emulsifier is: 1 part of Span 83, 2 parts of Tween 80,

再加入34份去离子水补足重量份数。Then add 34 parts of deionized water to make up the parts by weight.

步骤4:制备油相Step 4: Prepare the Oil Phase

将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温65℃,得到油相;Heat and stir the whitening active ingredient, soothing active ingredient and components of the oil phase in step 3 to dissolve, and keep warm at 65°C to obtain the oil phase;

步骤5:制备水相Step 5: Prepare the Water Phase

将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温65℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 65°C to obtain the water phase;

步骤6:制备初乳Step 6: Prepare Colostrum

将由步骤5得到的水相在剪切力为14000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质5min,得到初乳;Slowly add the water phase obtained in step 5 into the oil phase obtained in step 4 under the shear force of 14000r/min, and then homogenize for 5 minutes to obtain colostrum;

步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers

将步骤6得到的初乳,通过高压均质机在压力为500bar作用下均质5次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 5 times by a high-pressure homogenizer under the action of a pressure of 500 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.

检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.

实施例3Example 3

制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.

步骤3:物料准备Step 3: Material Preparation

按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:

美白活性成分包括:10份α-熊果苷、10份白藜芦醇。Whitening active ingredients include: 10 parts of α-arbutin, 10 parts of resveratrol.

舒缓活性成分包括:10份紫玉兰叶提取物、10份库拉索芦荟提取物。Soothing active ingredients include: 10 parts Magnolia Leaf Extract, 10 parts Aloe Vera Extract.

油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.

固体油脂包括:12份乳木果油、5份单甘脂、11份月桂醇。Solid fats include: 12 parts shea butter, 5 parts monoglyceride, 11 parts lauryl alcohol.

液体油脂包括:4份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 4 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.

乳化剂为:2份的司盘83、2份的吐温80,The emulsifier is: 2 parts of Span 83, 2 parts of Tween 80,

再加入20份去离子水补足重量份数。Then add 20 parts of deionized water to make up the parts by weight.

步骤4:制备油相Step 4: Prepare the Oil Phase

将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温70℃,得到油相;The whitening active ingredient, the soothing active ingredient and the components of the oil phase in step 3 are heated and stirred to dissolve, and kept at 70°C to obtain the oil phase;

步骤5:制备水相Step 5: Prepare the Water Phase

将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温70℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 70°C to obtain the water phase;

步骤6:制备初乳Step 6: Prepare Colostrum

将由步骤5得到的水相在剪切力为10000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质5min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 10000r/min, and then homogenize for 5 minutes to obtain colostrum;

步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers

将步骤6得到的初乳,通过高压均质机在压力为600bar作用下均质4次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 4 times by a high-pressure homogenizer under the action of a pressure of 600 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.

检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.

实施例4Example 4

制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.

步骤3:物料准备Step 3: Material Preparation

按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:

美白活性成分包括:8份α-熊果苷、6份白藜芦醇。Whitening active ingredients include: 8 parts of α-arbutin, 6 parts of resveratrol.

舒缓活性成分包括:7份紫玉兰叶提取物、8份库拉索芦荟提取物。Soothing active ingredients include: 7 parts Magnolia Leaf Extract, 8 parts Aloe Vera Extract.

油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.

固体油脂包括:12份乳木果油、7份单甘脂、11份月桂醇。Solid fats include: 12 parts shea butter, 7 parts monoglyceride, 11 parts lauryl alcohol.

液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.

乳化剂为:2份的司盘83、1份的吐温80,The emulsifier is: 2 parts of Span 83, 1 part of Tween 80,

再加入32份去离子水补足重量份数。Then add 32 parts of deionized water to make up the parts by weight.

步骤4:制备油相Step 4: Prepare the Oil Phase

将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温75℃,得到油相;Heat and stir the whitening active ingredient, soothing active ingredient and components of the oil phase in step 3 to dissolve, and keep warm at 75°C to obtain the oil phase;

步骤5:制备水相Step 5: Prepare the Water Phase

将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温75℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 75°C to obtain the water phase;

步骤6:制备初乳Step 6: Prepare Colostrum

将由步骤5得到的水相在剪切力为12000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质4min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 12000r/min, and then homogenize for 4 minutes to obtain colostrum;

步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers

将步骤6得到的初乳,通过高压均质机在压力为700bar作用下均质4次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 was homogenized four times by a high-pressure homogenizer at a pressure of 700 bar, and cooled rapidly to room temperature to obtain a whitening and soothing nanostructured lipid carrier.

检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.

实施例5Example 5

制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.

步骤3:物料准备Step 3: Material Preparation

按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:

美白活性成分包括:10份α-熊果苷、10份白藜芦醇。Whitening active ingredients include: 10 parts of α-arbutin, 10 parts of resveratrol.

舒缓活性成分包括:7份紫玉兰叶提取物、12份库拉索芦荟提取物。Soothing active ingredients include: 7 parts Magnolia Leaf Extract, 12 parts Aloe Vera Extract.

油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.

固体油脂包括:12份乳木果油、7份单甘脂、11份月桂醇。Solid fats include: 12 parts shea butter, 7 parts monoglyceride, 11 parts lauryl alcohol.

液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.

乳化剂为:2份的司盘83、2份的吐温80,The emulsifier is: 2 parts of Span 83, 2 parts of Tween 80,

再加入21份去离子水补足重量份数。Then add 21 parts of deionized water to make up the parts by weight.

步骤4:制备油相Step 4: Prepare the Oil Phase

将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温65℃,得到油相;Heat and stir the whitening active ingredient, soothing active ingredient and components of the oil phase in step 3 to dissolve, and keep warm at 65°C to obtain the oil phase;

步骤5:制备水相Step 5: Prepare the Water Phase

将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温65℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 65°C to obtain the water phase;

步骤6:制备初乳Step 6: Prepare Colostrum

将由步骤5得到的水相在剪切力为14000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质6min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 14000r/min, and then homogenize for 6 minutes to obtain colostrum;

步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers

将步骤6得到的初乳,通过高压均质机在压力为600bar作用下均质5次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 5 times by a high-pressure homogenizer under the action of a pressure of 600 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.

检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.

实施例6Example 6

检测美白舒缓的纳米结构脂质载体对斑马鱼胚胎安全性的影响。Examination of the effect of whitening and soothing nanostructured lipid carriers on the safety of zebrafish embryos.

斑马鱼胚胎安全性评价原理:将128细胞期斑马鱼胚胎暴露于受试物稀释液中96hpf,而后于显微镜下观察并记录具有凝结、没有心跳或尾巴未脱离特征的死亡鱼胚胎数目,计算胚胎死亡率。Zebrafish embryo safety evaluation principle: Expose zebrafish embryos at the 128-cell stage to 96hpf in the dilution of the test substance, then observe and record the number of dead fish embryos with the characteristics of condensation, no heartbeat or tail detachment under the microscope, and calculate the number of embryos mortality rate.

操作步骤:在产卵盒中按照1:2雌雄比配鱼产卵,在早上开灯刺激雌雄鱼交配,交配30min后收集胚胎,并用养殖水冲洗。Operation steps: In the spawning box, fish are paired with a male-to-female ratio of 1:2 to spawn. In the morning, the light is turned on to stimulate the male and female fish to mate. After 30 minutes of mating, the embryos are collected and rinsed with breeding water.

将6hpf胚胎放到体视显微镜下观察,筛选发育正常可用于后续实验的胚胎。将胚胎放置于24孔板中,每孔20枚胚胎,设置三组重复,在不伤害胚胎的情况下除去孔板中标准稀释水,向每孔中迅速加入1mL一定浓度的美白舒缓的纳米结构脂质载体的溶液(样品1)、将美白舒缓的纳米结构脂质载体原料产物不经过任何操作,直接以同浓度的组分进行简单的搅拌配置成同样浓度的、未包覆活性物纳米结构脂质载体溶液(样品2)以及空白溶液。The 6hpf embryos were observed under a stereomicroscope, and embryos with normal development were screened for subsequent experiments. Place the embryos in a 24-well plate, 20 embryos per well, set up three repetitions, remove the standard dilution water in the well plate without harming the embryos, and quickly add 1mL of a certain concentration of whitening and soothing nanostructures to each well Lipid carrier solution (sample 1), the whitening and soothing nanostructured lipid carrier raw material product is directly mixed with the same concentration of components to form the same concentration, uncoated active nanostructure Lipid carrier solution (sample 2) and blank solution.

在28.5℃恒温培养箱中避光孵育,每天观察胚胎的发育情况,及时移走死亡胚胎,更换100%药液,以免影响胚胎发育。暴露至96hpf后,观察记录胚胎的死亡数,计算死亡率。结果如图1所示。(P<0.01**;P<0.001***)。Incubate in the dark in a constant temperature incubator at 28.5°C, observe the development of the embryos every day, remove the dead embryos in time, and replace 100% of the drug solution, so as not to affect the development of the embryos. After exposure to 96hpf, the death number of embryos was observed and recorded, and the mortality rate was calculated. The result is shown in Figure 1. (P<0.01**; P<0.001***).

实施例7:Embodiment 7:

检测美白舒缓的纳米结构脂质载体对斑马鱼胚胎的美白功效影响Examination of the effect of whitening and soothing nanostructured lipid carrier on the whitening efficacy of zebrafish embryos

斑马鱼胚胎美白功效性评价原理:将24hpf的斑马鱼胚胎置于不同浓度受试物稀释液中至48hpf,根据黑色素在胚胎体表的沉积分布,观察黑色素颗粒分布的变化。Efficacy evaluation principle of zebrafish embryo whitening: place 24hpf zebrafish embryos in diluents of different concentrations of test substances to 48hpf, and observe the changes in the distribution of melanin granules according to the deposition and distribution of melanin on the embryo body surface.

操作步骤:在产卵盒中按照1:2雌雄比配鱼产卵,在早上开灯刺激雌雄鱼交配,交配30min后收集胚胎,并用养殖水冲洗。Operation steps: In the spawning box, fish are paired with a male-to-female ratio of 1:2 to spawn. In the morning, the light is turned on to stimulate the male and female fish to mate. After 30 minutes of mating, the embryos are collected and rinsed with breeding water.

放到体视显微镜下观察,筛选发育正常可用于后续实验的胚胎。选取发育正常的24hpf斑马鱼胚胎,放置于24孔板中,每孔20枚,设置三组重复,在不伤害胚胎的情况下除去孔板中标准稀释水,向每孔中迅速加入1mL一定浓度的美白舒缓的纳米结构脂质载体溶液以及空白溶液。Observe under a stereomicroscope to screen embryos that develop normally and can be used for subsequent experiments. Select 24hpf zebrafish embryos with normal development, place them in a 24-well plate, 20 embryos per well, set up three replicates, remove the standard dilution water in the well plate without harming the embryos, and quickly add 1mL of a certain concentration to each well Whitening and soothing nanostructured lipid carrier solution and blank solution.

在28.5℃恒温培养箱中避光孵育,孵育24hpf后,从表型和行为正常的斑马鱼中随机选取至少10尾斑马鱼,用3%甲基纤维素固定,在荧光显微镜下观察并拍照,使用图像分析软件对斑马鱼图片进行分析,以此来计算斑马鱼黑色素含量。结果如图2所示。(P<0.01**;P<0.001***;P<0.0001****)。结果表明,本发明的美白舒缓的纳米结构脂质载体,可明显抑制斑马鱼体表黑色素,具有显著地美白效果。Incubate in a constant temperature incubator at 28.5°C in the dark. After incubation for 24hpf, at least 10 zebrafish were randomly selected from zebrafish with normal phenotype and behavior, fixed with 3% methylcellulose, observed and photographed under a fluorescent microscope, Use image analysis software to analyze the zebrafish pictures to calculate the melanin content of the zebrafish. The result is shown in Figure 2. (P<0.01**; P<0.001***; P<0.0001****). The results show that the whitening and soothing nano-structured lipid carrier of the present invention can obviously inhibit the melanin on the body surface of zebrafish, and has a remarkable whitening effect.

实验例8Experimental example 8

检测美白舒缓的纳米结构脂质载体对斑马鱼胚胎的舒缓功效影响Testing the soothing efficacy of whitening and soothing nanostructured lipid carriers on zebrafish embryos

斑马鱼胚胎舒缓功效性评价原理:将24hpf的斑马鱼胚胎置于不同浓度受试物稀释液中,孵育一段时间后,观察胚胎的翻滚情况,以此评价受试物的舒缓功效情况。The principle of evaluating the soothing efficacy of zebrafish embryos: place 24hpf zebrafish embryos in diluents of different concentrations of the test substance, and after incubation for a period of time, observe the rolling of the embryos to evaluate the soothing effect of the test substance.

操作步骤:在产卵盒中按照1:2雌雄比配鱼产卵,在早上开灯刺激雌雄鱼交配,交配30min后收集胚胎,并用养殖水冲洗。放到体视显微镜下观察,筛选发育正常可用于后续实验的胚胎。Operation steps: In the spawning box, fish are paired with a male-to-female ratio of 1:2 to spawn. In the morning, the light is turned on to stimulate the male and female fish to mate. After 30 minutes of mating, the embryos are collected and rinsed with breeding water. Observe under a stereomicroscope to screen embryos that develop normally and can be used for subsequent experiments.

选取发育正常的24hpf斑马鱼胚胎,放置于96孔板中,每孔5枚胚胎,设置3组重复,在不伤害胚胎的情况下除去孔板中标准稀释水,并加入不同浓度美白舒缓的纳米结构脂质载体的稀释液,空白对照组和模型对照组加入缓冲水,阳性对照组加入造模剂,孵育一个小时,孵育结束后除去孔中液体,空白组加入缓冲水,模型组加入SDS溶液,受试物中加入造模剂配制的溶液,孵育15min后,记录每枚胚胎在30s内翻滚次数。结果如图3所示。Select 24hpf zebrafish embryos with normal development, place them in a 96-well plate, 5 embryos per well, set up 3 groups of repetitions, remove the standard dilution water in the well plate without harming the embryos, and add different concentrations of whitening and soothing nano Dilution of structured lipid carrier, add buffer water to the blank control group and model control group, add modeling agent to the positive control group, incubate for one hour, remove the liquid in the well after incubation, add buffer water to the blank group, and add SDS solution to the model group , adding the solution prepared by the modeling agent to the test substance, and after incubation for 15 minutes, record the number of times each embryo rolled over within 30 seconds. The result is shown in Figure 3.

结果表明,本发明的美白舒缓的纳米结构脂质载体,可明显减少斑马鱼胚胎的翻滚次数,具有显著地舒缓效果。The results show that the whitening and soothing nano-structured lipid carrier of the present invention can significantly reduce the number of tumbling times of zebrafish embryos, and has a significant soothing effect.

实施例9:一种美白乳液(美白舒缓的纳米结构脂质载体的应用)Embodiment 9: A kind of whitening emulsion (the application of nanostructure lipid carrier that whitens and relieves)

以美白舒缓的纳米结构脂质载体作为关键组分制备美白乳液,按质量百分比计包括以下组分:The whitening emulsion is prepared with the whitening and soothing nano-structured lipid carrier as the key component, which includes the following components by mass percentage:

Figure BDA0003821579500000131
Figure BDA0003821579500000131

制备方法:Preparation:

将A相、B相、C相的各个组分分别搅拌混合后备用。首先将A和B两相分别加热至80℃,溶解混合均匀,将A相加入到B相中,并均质5min,在转速为8000rpm/min搅拌,随后冷却至50℃时,加入C相并均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B and Phase C separately and set aside for later use. First, heat A and B phases to 80°C respectively, dissolve and mix evenly, add phase A into phase B, and homogenize for 5 minutes, stir at a speed of 8000rpm/min, then cool to 50°C, add phase C and mix Homogenize for 2 minutes, pack after aging for 24 hours.

实施例10:一种美白面膜液(美白舒缓的纳米结构脂质载体的应用)Embodiment 10: A kind of whitening mask liquid (the application of nanostructure lipid carrier that whitens and relieves)

以美白舒缓的纳米结构脂质载体作为关键组分制备美白面膜液,按质量百分比计包括以下组分:The whitening mask liquid is prepared with the whitening and soothing nano-structured lipid carrier as the key component, which includes the following components by mass percentage:

Figure BDA0003821579500000141
Figure BDA0003821579500000141

制备方法:Preparation:

将A相、B相、C相的各个组分分别搅拌混合后备用。依次将A、B两相称好,将A和B相加热至80℃,溶解到无颗粒,转速为1000rpm/min搅拌均匀,将B相加入到A相中,均质5min,搅拌降温至50℃,加入C相,转速为800rpm/min低速均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B and Phase C separately and set aside for later use. Mix phases A and B in turn, heat phases A and B to 80°C, dissolve until there are no particles, stir at a speed of 1000rpm/min, add phase B to phase A, homogenize for 5min, stir and cool down to 50°C , add phase C, homogenize at a low speed of 800rpm/min for 2min, age for 24h and pack.

实施例11,人体试用评价实验Embodiment 11, human body trial evaluation experiment

1.实验方法1. Experimental method

以实施例9:一种美白乳液(美白舒缓的纳米结构脂质载体的应用);实施例10:一种美白面膜液(美白舒缓的纳米结构脂质载体的应用)进行人体试用评价。Example 9: a whitening emulsion (application of whitening and soothing nanostructured lipid carrier); embodiment 10: a whitening mask liquid (application of whitening and soothing nanostructured lipid carrier) for human trial evaluation.

选取18~60岁的志愿者50名,分为两组。使用方法为每日洁面后使用,每天两次(早晚各涂一次),一组的左脸使用按实施例9制备的乳液,一组的左脸使用按实施例10制备的面膜液;两组的右脸使用其平时日常使用的一种无任何特殊功效(特别是不具备任何美白或舒缓成分)的基础护肤品(记录具体产品名称及型号)。Select 50 volunteers aged 18-60 and divide them into two groups. The method of use is to use after cleansing every day, twice a day (respectively apply once in the morning and evening), the left face of one group uses the emulsion prepared by embodiment 9, and the left face of one group uses the facial mask liquid prepared by embodiment 10; two groups The right face of the patient uses a basic skin care product (record the specific product name and model) that he usually uses without any special effects (especially without any whitening or soothing ingredients).

实验期为两个月,试验期间受试部位不使用其他化妆品,使用两个月后观察左脸和右脸的肤色和斑点、暗沉情况以及肌肤的敏感性。The test period is two months. During the test period, no other cosmetics are used on the test site. After two months of use, the skin color, spots, dullness and skin sensitivity of the left and right faces are observed.

2.实验结果2. Experimental results

使用两个月后发现,有合计44名志愿者使用了按实施例9制备的乳液、按实施例10制备的面膜液的左脸的肤色都能够好于其右脸,并且左脸的斑点和暗沉情况明显改善,同时,肌肤的抗敏性提高。可以认为该有效率高达88%。After two months of use, it was found that a total of 44 volunteers had used the emulsion prepared in Example 9 and the skin color of the facial mask liquid prepared in Example 10. The skin color of the left face can be better than that of the right face, and the spots and The dullness is significantly improved, and at the same time, the skin's anti-sensitivity is improved. It is considered that the effective rate is as high as 88%.

本发明所制备的美白舒缓的纳米结构脂质载体可广泛应用到化妆品领域中,如膏霜、乳液、精华液、面膜等不同剂型的化妆品中,或美白、抗炎、抗衰、保湿等不同功效化妆品中,具有较好的应用价值。The whitening and soothing nanostructured lipid carrier prepared by the present invention can be widely used in the field of cosmetics, such as creams, lotions, essences, facial masks and other cosmetics of different formulations, or different formulations such as whitening, anti-inflammatory, anti-aging, moisturizing, etc. In functional cosmetics, it has good application value.

最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than limiting them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present invention. scope.

Claims (9)

1. A preparation method of a nano-structure lipid carrier for whitening and soothing is characterized by comprising the following steps:
step 1: preparation method of Magnolia liliiflora leaf extract
Cleaning fresh magnolia liliflora leaves, draining and drying; drying until the surface is free of moisture and less than 70% of the original weight, and grinding into powder of Magnolia liliiflora leaves with a grinder;
ultrasonically crushing and extracting dried magnolia liliiflora leaf powder with absolute ethyl alcohol for 3 times, combining extracting solutions, and distilling under reduced pressure to remove an organic solvent to obtain an magnolia liliiflora leaf extract;
and 2, step: preparation method of Aloe Barbadensis Miller extract
Repeatedly washing Aloe vera, wiping surface, removing edge thorn, peeling epidermis from transparent gel surface, and washing off yellow juice on gel surface with clear water;
cutting Aloe vera into small pieces, stirring with tissue mixer to homogenate, centrifuging homogenate for 12000r/min, and removing precipitate after 15min to obtain Aloe vera gel juice;
vacuum concentrating Aloe vera gel juice in a rotary evaporator at 60 deg.C to 35% of original volume, adding 10 times volume of 95% ethanol, cooling to 4 deg.C, and precipitating with ethanol for 24 hr;
centrifuging the obtained Aloe barbadensis Miller mixed precipitate at 5000r/min for 15min, collecting precipitate, and freeze drying to obtain Aloe barbadensis Miller crude extract;
dissolving 10g of crude extract of Aloe barbadensis Miller in 1000mL of deionized water to prepare 1.0% aqueous solution;
slowly adding ammonium sulfate solution into the above solution at room temperature, rapidly stirring the ammonium sulfate solution until the mass fraction of ammonium sulfate in the crude extract solution of Aloe Barbadensis Miller reaches 40%, and standing the mixed product at 4 deg.C for 24 hr;
centrifuging the product at 5000r/min for 15min, dissolving precipitate in water, dialyzing until no ammonium sulfate residue is left, and lyophilizing to obtain Aloe Barbadensis Miller extract;
and step 3: material preparation
The materials calculated by the total weight of 100 parts are as follows:
10-30 parts of whitening active ingredients, 10-20 parts of soothing active ingredients, 25-36 parts of components of an oil phase, 1-4 parts of an emulsifier and the balance of deionized water;
wherein the soothing active ingredient is an magnolia liliiflora leaf extract and an aloe barbadensis extract prepared by the methods of steps 1 and 2;
and 4, step 4: preparation of the oil phase
Heating, stirring and dissolving the whitening active ingredients, the soothing active ingredients and the components of the oil phase in the step 3, and keeping the temperature at 60-80 ℃ to obtain the oil phase;
and 5: preparation of the aqueous phase
Heating, stirring and dissolving the emulsifier and the deionized water in the step 3, and keeping the temperature at 60-80 ℃ to obtain a water phase;
and 6: preparation of colostrum
Slowly adding the water phase obtained in the step (5) into the oil phase obtained in the step (4) under the action of the shearing force of 10000-16000 r/min, and then homogenizing for 2-10 min to obtain primary emulsion;
and 7: preparation of nanostructured lipid Carriers
Homogenizing the colostrum obtained in the step 6 for 2-5 times under the action of 500-800 bar of pressure by a high-pressure homogenizer, and rapidly cooling to room temperature to obtain the whitening and relieving nano-structure lipid carrier.
2. The whitening-soothing nanostructured lipid carrier of claim 1, wherein:
the particle size of the nano-structured lipid carrier is between 200 and 600 nm.
3. The whitening-soothing nanostructured lipid carrier of claim 1, wherein:
the whitening active components comprise 5-15 parts of alpha-arbutin and 5-15 parts of resveratrol.
4. The whitening-soothing nanostructured lipid carrier of claim 1, wherein:
the components of the oil phase are 10-16 parts of shea butter, 5-11 parts of monoglyceride, 10-15 parts of lauryl alcohol, 1-6 parts of caprylic/capric triglyceride and 2-8 parts of isooctyl palmitate.
5. The whitening-soothing nanostructured lipid carrier of claim 1, wherein:
the emulsifier is as follows: 1-4 parts of span 83 and 2-3 parts of Tween 80.
6. The whitening emulsion of any of claims 1-5, wherein the nanostructured lipid carrier is configured to: the whitening emulsion comprises the following components in percentage by mass:
Figure FDA0003821579490000031
7. a whitening emulsion with the incorporation of a whitening soothing nanostructured lipid carrier according to any of claims 1 to 5, characterized in that it is prepared by a process comprising the following steps:
respectively stirring and mixing the components of the phase A, the phase B and the phase C for later use; respectively heating the phase A and the phase B to 80 ℃, dissolving and mixing uniformly, adding the phase A into the phase B, homogenizing for 5min, stirring at the rotation speed of 8000rpm/min, cooling to 50 ℃, adding the phase C, homogenizing for 2min, aging for 24h, and packaging.
8. The whitening and soothing nanostructured lipid carrier according to any of claims 1 to 5, involved in the preparation of a whitening mask solution, characterized in that: the whitening mask liquid comprises the following components in percentage by mass:
Figure FDA0003821579490000041
9. the whitening mask solution with the participation of the whitening and soothing nano-structured lipid carrier in the preparation of any one of claims 1 to 5, characterized in that the preparation method comprises the following steps:
respectively stirring and mixing the components of the phase A, the phase B and the phase C for later use; weighing the phase A and the phase B in sequence, heating the phase A and the phase B to 80 ℃, dissolving until no particles exist, uniformly stirring at the rotation speed of 1000rpm/min, adding the phase B into the phase A, homogenizing for 5min, stirring, cooling to 50 ℃, adding the phase C, homogenizing at the rotation speed of 800rpm/min for 2min at a low speed, aging for 24h, and packaging.
CN202211056118.7A 2022-08-29 2022-08-29 Preparation and application of skin-whitening and soothing nano-structure lipid carrier Pending CN115350133A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211056118.7A CN115350133A (en) 2022-08-29 2022-08-29 Preparation and application of skin-whitening and soothing nano-structure lipid carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211056118.7A CN115350133A (en) 2022-08-29 2022-08-29 Preparation and application of skin-whitening and soothing nano-structure lipid carrier

Publications (1)

Publication Number Publication Date
CN115350133A true CN115350133A (en) 2022-11-18

Family

ID=84004960

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211056118.7A Pending CN115350133A (en) 2022-08-29 2022-08-29 Preparation and application of skin-whitening and soothing nano-structure lipid carrier

Country Status (1)

Country Link
CN (1) CN115350133A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107115232A (en) * 2017-04-25 2017-09-01 广州雅纯化妆品制造有限公司 A kind of liquid of releiving of refreshing oneself applied to cosmetics
CN109646376A (en) * 2019-01-25 2019-04-19 金怡文 A kind of whitening moisturizing face masque and preparation method thereof
CN110664643A (en) * 2019-10-30 2020-01-10 长春市奢脉嘉天化妆品有限公司 Polypeptide essence with multiple-effect whitening effect and preparation method thereof
CN114010546A (en) * 2021-11-19 2022-02-08 广东轻工职业技术学院 Multi-load whitening synergistic nanostructured lipid carrier and preparation method thereof
CN114712274A (en) * 2021-12-23 2022-07-08 上海交通大学医学院附属第九人民医院 Soothing and anti-allergy nano vesicle composition and application thereof
CN114886813A (en) * 2022-05-27 2022-08-12 广州环亚化妆品科技股份有限公司 Anti-aging plant extract composition and preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107115232A (en) * 2017-04-25 2017-09-01 广州雅纯化妆品制造有限公司 A kind of liquid of releiving of refreshing oneself applied to cosmetics
CN109646376A (en) * 2019-01-25 2019-04-19 金怡文 A kind of whitening moisturizing face masque and preparation method thereof
CN110664643A (en) * 2019-10-30 2020-01-10 长春市奢脉嘉天化妆品有限公司 Polypeptide essence with multiple-effect whitening effect and preparation method thereof
CN114010546A (en) * 2021-11-19 2022-02-08 广东轻工职业技术学院 Multi-load whitening synergistic nanostructured lipid carrier and preparation method thereof
CN114712274A (en) * 2021-12-23 2022-07-08 上海交通大学医学院附属第九人民医院 Soothing and anti-allergy nano vesicle composition and application thereof
CN114886813A (en) * 2022-05-27 2022-08-12 广州环亚化妆品科技股份有限公司 Anti-aging plant extract composition and preparation method and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
丁林芬等: ""紫玉兰叶中木脂素类成分及抗炎活性研究"", 《中草药》, vol. 53, no. 13, 6 July 2022 (2022-07-06), pages 3912 - 3919 *
万德光主编: "《中药品种品质与药效》", 31 December 2007, 上海科学技术出版社, pages: 539 - 541 *
书金等编著: "《塑造丽人完美肌肤》", 31 July 2004, 吉林大学出版社, pages: 156 *
李峰等: ""紫玉兰叶油化学成分的气相色谱/质谱法分析"", 《分析化学》, no. 07, 25 July 2000 (2000-07-25), pages 829 - 832 *
谭志坚: ""双水相萃取体系在分离纯化芦荟活性成分中的应用研究"", 《中国博士学位论文全文数据库》, 15 February 2014 (2014-02-15), pages 1 - 149 *

Similar Documents

Publication Publication Date Title
US10004678B2 (en) Anti-dandruff compositions, and methods of use thereof
JP7275103B2 (en) Novel cosmetic use of Nephelium lapaceum extract
JP6387219B2 (en) Skin external preparation composition containing tangeretin and EGCG
FR2684300A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION, PARTICULARLY DERMATOLOGICAL, IN PARTICULAR FOR PROMOTING THE PIGMENTATION OF SKIN OR HAIR, CONTAINING A BALLOTE EXTRACT, AND METHOD FOR PRODUCING THE SAME.
CN115074393A (en) Pichia pastoris fermentation lysate filtrate, preparation method and application
CN106994135A (en) Sea grape extract with function of inhibiting allergy, preparation method and application
WO2001074326A1 (en) Agents improving skin barrier function
US10898429B2 (en) Uses of coffee pulp extract
JP2000044485A (en) Active oxygen species scavenger and skin cosmetic
WO2022164804A1 (en) Nano- or micro-emulsion compositions and methods of use thereof
CN115350133A (en) Preparation and application of skin-whitening and soothing nano-structure lipid carrier
KR100532633B1 (en) Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract
JP2002037709A (en) Skin care preparation
WO2015036704A1 (en) Cosmetic or dermatological use of an extract of tapirira guianensis
US20240156716A1 (en) Cosmetic use of a solanum lycopersicum fruit (tomato) skin extract
Xu et al. An ionic liquid nanoparticles for dermal targeted delivery and effective anti-wrinkle treatment
JP3611553B2 (en) Skin preparation
CN118178285A (en) Application of Sorbus nigra extract in skin care product and cosmetics
CN115414286A (en) Cosmetic composition for skin allergy relief containing Phaeodactylum tricornutum complex extract as active ingredient
WO2023161288A1 (en) Moabi cake hydrolysate and preparation method and cosmetic use thereof, particularly for the treatment of ageing skin and skin depigmentation
FR3145488A1 (en) Cosmetic use of a combination of plant extracts.
WO2024023440A1 (en) Novel cosmetic or dermatological use of a gentiana crassicaulis extract
CN118267313A (en) Bionic nano chlorophyll wrapped by fat-soluble biological film, preparation method thereof and application of bionic nano chlorophyll in anti-atrophy photoaging
KR20220042759A (en) Composition for preventing or treating hair loss comprising spirulina extract
CN117412755A (en) Compositions comprising plant-derived exosome-like nanovesicles or exosomes and methods of use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination